<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05059197</url>
  </required_header>
  <id_info>
    <org_study_id>PNK-20D21-FF1R</org_study_id>
    <nct_id>NCT05059197</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of AP Collagen Peptide on the Skin</brief_title>
  <official_title>Evaluation of Skin Health Improvement and Safety in AP Collagen Peptide: Randomized, Double-blind, Placebo-controlled</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amorepacific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amorepacific Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This double-blinded, randomized, placebo-controlled study aimed to evaluate the efficacy and&#xD;
      safety of AP collagen peptides (APCP) containing 3% Glycine-Proline-Hydroxyproline (GPH) on&#xD;
      improving skin health. Subjects with dried skin were randomly assigned to receive placebo or&#xD;
      APCP once daily for 12 weeks.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2020</start_date>
  <completion_date type="Actual">October 12, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in epidermal hydration</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>skin hydration measured by MoistureMeter-D compact</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in skin roughness (texture)</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>skin roughness measured by PRIMOS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in skin gloss</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>skin roughness measured by Skinglossmeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in stratum corneum condition</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>stripped using 10 tape strips (D-Squame) and measured by VisioScan</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Ceramides in stratum corneum</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>ultra-performance liquid chromatography system etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Natural moisturizing factor in stratum corneum</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>Ultra-performance liquid chromatography system etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in TEWL</measure>
    <time_frame>Baseline, 12 week</time_frame>
    <description>Transepidermal water loss measured by vapometer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Dry Skin</condition>
  <arm_group>
    <arm_group_label>AP collagen peptide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each subject takes one active bottle per day for 12 weeks. Each bottle contains AP collagen 1000 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Each subject takes one active bottle per day for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>AP collagen peptide</intervention_name>
    <description>Health functional food</description>
    <arm_group_label>AP collagen peptide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Those whose eye wrinkles are Grade 3 or higher in the visual evaluation&#xD;
&#xD;
          -  Those whose moisture retention in both cheeks measured by CorneometerÂ® is 49 A.U. or&#xD;
             less&#xD;
&#xD;
          -  A person who has agreed to participate in this human application test before the start&#xD;
             of the human application test and filled out the Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those with skin diseases such as atopic dermatitis and psoriasis&#xD;
&#xD;
          -  Those who are sensitive to or allergic to the food ingredients for this trial foods&#xD;
&#xD;
          -  Those with skin abnormalities such as spots, acne, erythema, and hypersensitive skin&#xD;
             at the test site&#xD;
&#xD;
          -  People who take diet pills (absorbent and antidepressants, appetite suppressants,&#xD;
             etc.) and contraceptives or hormones or diuretics within one month based on visit1&#xD;
&#xD;
          -  Those who have used functional cosmetics for wrinkle improvement, highly moisturizing&#xD;
             cosmetics, or skincare devices within 2 weeks of visit 1&#xD;
&#xD;
          -  A person who used steroid-containing outer skin for more than one month to treat skin&#xD;
             diseases&#xD;
&#xD;
          -  A person who has received chemical and physical treatment (pattern, epidermis, lasers,&#xD;
             procedures, etc.) in the test area within six months prior to the start of the test&#xD;
&#xD;
          -  Visit 1 A person who has participated in other interventional clinical tests&#xD;
             (including human application tests) within one month of the standard or plans to&#xD;
             participate in other interventional clinical tests (including human application tests)&#xD;
             after the start of this human application test&#xD;
&#xD;
          -  A person who judges that the tester is inappropriate for this test&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hae Kwang Lee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>P&amp;K Skin Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>P&amp;K Skin Research Center</name>
      <address>
        <city>Seoul</city>
        <zip>07236</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 17, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

